載入...
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following molecular profiling has dramatically changed the way advanced adenocarcinoma is treated. However, tumor cells inevitably acquire resistance to such therapies, circumventing any sustained clinical benefit. A...
Na minha lista:
| 發表在: | J Mol Med (Berl) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5696571/ https://ncbi.nlm.nih.gov/pubmed/24852181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-014-1165-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|